{
    "id": 32160,
    "fullName": "EMC2 - RSPO2",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "EMC2-RSPO2 results from the fusion of EMC2 and RSPO2, which results in increased Wnt pathway signaling in a reporter assay, elevated beta-catenin expression, and an increased rate of tumor growth in mouse models (PMID: 30250044). EMC2-RSPO2 has been identified in gastric cancer (PMID: 30250044).",
            "references": [
                {
                    "id": 17432,
                    "pubMedId": 30250044,
                    "title": "Identification of RSPO2 Fusion Mutations and Target Therapy Using a Porcupine Inhibitor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30250044"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 9694,
        "geneSymbol": "EMC2",
        "terms": [
            "EMC2",
            "KIAA0103",
            "TTC35"
        ]
    },
    "variant": "EMC2 - RSPO2",
    "createDate": "01/21/2020",
    "updateDate": "01/21/2020",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 340419,
                "geneSymbol": "RSPO2",
                "terms": [
                    "RSPO2",
                    "CRISTIN2",
                    "HHRRD",
                    "TETAMS2"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 19885,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CGX1321 treatment inhibited tumor growth and led to decreased expression of AXIN in a patient-derived xenograft (PDX) model of gastric cancer harboring EMC2-RSPO2 (PMID: 30250044).",
            "molecularProfile": {
                "id": 34654,
                "profileName": "EMC2 - RSPO2"
            },
            "therapy": {
                "id": 6584,
                "therapyName": "CGX1321",
                "synonyms": null
            },
            "indication": {
                "id": 10534,
                "name": "stomach cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17432,
                    "pubMedId": 30250044,
                    "title": "Identification of RSPO2 Fusion Mutations and Target Therapy Using a Porcupine Inhibitor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30250044"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34654,
            "profileName": "EMC2 - RSPO2",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}